SCHEMBL22837219

SCHEMBL22837219

BOc1cc2ccccc2nc1P(=O)(c1ccccc1)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TLR8 Q9NR97 5/20 0.37
▸ MAPT P10636 6/20 0.37
▸ ALDH1A1 P00352 4/20 0.37
▸ HPGD P15428 2/20 0.37
▸ GLA P06280 1/20 0.37
▸ ACHE P22303 1/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ HTT P42858 2/20 0.36
▸ STAT3 P40763 1/20 0.36
▸ NPSR1 Q6W5P4 3/20 0.34
▸ KDM4E B2RXH2 3/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ MGAM O43451 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ ALOX12 P18054 1/20 0.33
▸ KDR P35968 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16401011 0.76 KDM4E (0.47) MAPTALDH1A1HPGDGLAACHE
Lithium Ion SCHEMBL16401318 0.75 ALDH1A1 (0.39) MAPTALDH1A1HPGDGLAACHE
SCHEMBL16401320 0.75 KDM4E (0.46) MAPTALDH1A1HPGDGLAACHE
SCHEMBL11280043 0.74 MAPT (0.43) MAPTALDH1A1HPGDSMN1; SMN2HTT
SCHEMBL18976995 0.70 ALDH1A1 (0.40) MAPTALDH1A1HPGDSMN1; SMN2HTT
SCHEMBL11275569 0.67 NPSR1 (0.44) MAPTALDH1A1HPGDSMN1; SMN2HTT
SCHEMBL18928651 0.66 ALDH1A1 (0.57) MAPTALDH1A1HTTNPSR1MEN1
SCHEMBL21226285 0.66 ALDH1A1 (0.53) ALDH1A1HTTNPSR1MEN1POLB
SCHEMBL21503919 0.66 KDR (0.50) MAPTALDH1A1SMN1; SMN2NPSR1KDM4E
SCHEMBL16401204 0.65 MGAM (0.48) MAPTALDH1A1HPGDSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10879473-B2 Organic electronic device NOVALED GMBH (DE) 2020-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10879473-B2 Organic electronic device OR10J3, LAGE3, L1CAM TLR8 3786/4885MAPT 527/4885ALDH1A1 886/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback